The transaction is sourced from an SEC EDGAR Form S-4 filing published on September 25, 2025. Based on the facts provided, the deal's status is pending regulatory approval.
On the financial advisory side, PJT Partners LP served as financial advisor to Core Scientific, the target, and is identified as the lead advisor in this transaction. The source material is drawn from a consent letter referencing the inclusion of PJT Partners's opinion letter, cited under the headings "Summary, Opinions of Core Scientific's Financial Advisors" and "The Merger, Opinions of Core Scientific's Financial Advisors, Opinion of PJT Partners," confirming that PJT Partners rendered a fairness opinion to Core Scientific in connection with the merger. No financial advisor to CoreWeave, the acquirer, is identified in the facts provided.
No legal advisor is identified for either party in the facts provided for this transaction.
Beyond confirming that the transaction is structured as a stock-for-stock merger, no further detail on the specific exchange ratio or other terms of the stock consideration is included in the facts available.
Several elements of this deal remain undisclosed. The deal value is explicitly noted as not stated in the source document, and no legal advisor to either Core Scientific or CoreWeave is identified. The heading referenced in the source material notes "Opinions of Core Scientific's Financial Advisors" in the plural, suggesting more than one advisor to Core Scientific may be involved, but only PJT Partners is named in the facts available, and no financial advisor to CoreWeave, the exchange ratio, or an expected closing date is provided.